Quale ruolo per gli studi non randomizzati nel pre- e post-marketing?

Recenti Prog Med. 2019 Nov;110(11):526-527. doi: 10.1701/3265.32349.
[Article in Italian]
No abstract available

MeSH terms

  • Commerce
  • Drug Approval* / legislation & jurisprudence
  • Drug Approval* / methods
  • Europe
  • Evidence-Based Medicine / methods
  • Humans
  • Non-Randomized Controlled Trials as Topic*
  • Observational Studies as Topic / methods
  • Pharmacovigilance*
  • Randomized Controlled Trials as Topic / methods
  • Risk Assessment
  • United States
  • United States Food and Drug Administration